-

XIFR INVESTOR ALERT: Kirby McInerney LLP Alerts XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP alerts investors of the imminent September 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP (“XPLR” or the “Company”) (NYSE:XIFR) securities during the period from September 27, 2023 and January 27, 2025 (“the Class Period”). The firm encourages investors to contact the firm as soon as possible to be appointed lead plaintiff.

[LEARN MORE ABOUT THE CLASS ACTION]

On January 28, 2025, XPLR announced that it would suspend cash distributions to common unitholders entirely and essentially abandon its yieldco model. In a press release, XPLR revealed a strategic repositioning and stated that the Company was moving from a business model that focused almost entirely on raising new capital to acquire assets while distributing substantially all of its excess cash flows to unitholders to a model in which XPLR Infrastructure utilizes retained operating cash flows to fund attractive investments. In addition, XPLR announced that the Company’s CEO and CFO had both resigned and been replaced. On this news, the price of XPLR’s common units declined by $5.31, or approximately 33.6%, from $15.80 per unit on January 27, 2025 to close at $10.49 per unit on January 29, 2025.

The lawsuit alleges that XPLR made materially false and/or misleading statements regarding the Company’s: (i) struggle to maintain its operations as a yieldco; (ii) financing arrangements which were made while downplaying the attendant risks; (iii) inability to resolve those financings before their maturity date without risking unitholder dilution, and (iv) plan to halt cash distributions to investors and redirect funds to resolve those financings.

If you purchased or otherwise acquired XPLR securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters without any cost to you.

[CONTACT FORM]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NYSE:XIFR

Release Versions

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

VITAL FARMS, INC. ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Vital Farms, Inc. (“Vital Farms” or the “Company”) (NASDAQ:VITL) securities during the period of May 8, 2025 through February 26, 2026, inclusive (“the Class Period”). If you suffered a loss on your Vital Farms investments, you have until May 26, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED...

ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 24, 2026, Culper Research published a report on ADMA alleging “Channel Stuffing, an Undisclos...

IBRX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of ImmunityBio, Inc. Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) securities during the period of January 19, 2026 through March 24, 2026, inclusive (“the Class Period”). If you suffered a loss on your ImmunityBio investments, you have until May 26, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERE...
Back to Newsroom